Recent Finacing
Recent Raise
Thrombolex is a commercial-stage developer of a pharmacomechanical lysis platform and FDA-cleared Bashir endovascular catheter systems for treating pulmonary embolism and other thromboembolic diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Thrombolex.
